To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene COQ2TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
140 supporting clones for gene COQ2 back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
AJ621061 liver and muscle .a 1 to 1617 1 to 1617 V66L tiling clone, AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 1617/1617
(100 %)
8 diff
(99.6 %id)
NM_015697.7   .a 1 to 1639 1 to 1639 exact RefSeq, AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 1639/1639
(100 %)
0 diff
(100 %id)
CB959599 Human Placenta, placenta .a 91 to 692 28 to 630       603/840
(71 %)
8 diff
(99.1 %id)
BG542782 lung .a 103 to 718 1 to 618       618/619
(99 %)
22 diff
(96.5 %id)
BC020728 lung .a 104 to 1638 1 to 1535   available from MGC, AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 1535/1536
(99 %)
3 diff
(99.9 %id)
BF790994 muscle (skeletal) .a 113 to 658 1 to 557       557/704
(79 %)
27 diff
(96.2 %id)
BG699931 brain, hippocampus .a 115 to 880 1 to 768   tiling clone,   768/768
(100 %)
8 diff
(99.0 %id)
DB481006 hippocampus .a 120 to 589 1 to 470       470/470
(100 %)
1 diff
(99.8 %id)
DA928032 small intestine .a 121 to 692 2 to 573   capped   572/573
(99 %)
3 diff
(99.5 %id)
BF691360 melanotic melanoma, high MDR, skin .a 124 to 887 1 to 767       767/775
(98 %)
27 diff
(96.6 %id)
BF692417 melanotic melanoma, high MDR, skin .a 124 to 685 1 to 569       569/882
(64 %)
14 diff
(98.5 %id)
CN264652 embryonic stem cells, cell lines H1, H7, andH9 .a 125 to 255 12 to 142       131/142
(92 %)
0 diff
(100 %id)
BG611128 adenocarcinoma, Prostate .a 130 to 875 1 to 765       765/770
(99 %)
41 diff
(94.7 %id)
BU786304 Pancreas, Purified pancreatic islet .a 131 to 600 1 to 470       470/470
(100 %)
10 diff
(97.9 %id)
DR006500 Spleen .a 133 to 812 13 to 692       680/692
(98 %)
2 diff
(99.8 %id)
BC008804 Skin, melanotic melanoma. .a 144 to 1639 1 to 1496   available from MGC, AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 1496/1496
(100 %)
2 diff
(99.9 %id)
BG171856 hypernephroma, cell line, Kidney .a 152 to 903 13 to 761       746/967
(77 %)
32 diff
(96.7 %id)
BE735833 adenocarcinoma, Pancreas .a 154 to 879 1 to 722       722/760
(95 %)
18 diff
(97.7 %id)
BE735549 adenocarcinoma, Pancreas .a 155 to 925 1 to 779       779/822
(94 %)
30 diff
(96.4 %id)
BX356872 Placenta Cot 25-normalized .a 157 to 908 1 to 752   fully sequenced, AAA   752/752
(100 %)
5 diff
(99.4 %id)
BF026793 melanotic melanoma, skin .a 163 to 1000 1 to 836       833/890
(93 %)
27 diff
(97.0 %id)
TI_57186051   .a 166 to 972 48 to 847       800/803
(99 %)
17 diff
(97.9 %id)
BI856190 breast, mammary adenocarcinoma, cell line .a 167 to 972 1 to 799       799/802
(99 %)
17 diff
(97.9 %id)
BX387830 Placenta Cot 25-normalized .a 179 to 1021 1 to 839   fully sequenced,   839/839
(100 %)
9 diff
(99.0 %id)
BM802956 duodenal adenocarcinoma, cell line, small intestine .a 332 to 1205 4 to 897       894/1044
(85 %)
26 diff
(97.6 %id)
BF382951 brain, primitive neuroectoderm .a 364 to 917 1 to 554       556/556
(100 %)
13 diff
(97.7 %id)
BM794033 Ascites, stomach .a 427 to 958 1 to 532       532/532
(100 %)
2 diff
(99.7 %id)
CR598020 HeLa cells Cot 25-normalized .a 433 to 1641 1 to 1209   tiling clone,   1209/1209
(100 %)
0 diff
(100 %id)
BX342077   .a 433 to 1344 1 to 903       903/926
(97 %)
16 diff
(98.3 %id)
CK906070 Islets of Langerhans, Pancreas .a 501 to 1095 1 to 595       595/595
(100 %)
1 diff
(99.9 %id)
BM453341 melanotic melanoma, skin .a 515 to 1362 1 to 857       857/935
(91 %)
33 diff
(96.5 %id)
BM127427 Islets of Langerhans, Pancreas .a 517 to 1021 1 to 506       506/506
(100 %)
2 diff
(99.7 %id)
BM126855 Islets of Langerhans, Pancreas .a 517 to 1071 1 to 555     Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 555/555
(100 %)
2 diff
(99.7 %id)
BF246860 brain, glioblastoma .a 526 to 1219 27 to 719       691/875
(78 %)
53 diff
(94.0 %id)
CV813866 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .a 556 to 1304 1 to 749       749/754
(99 %)
7 diff
(99.1 %id)
CN366451 embryonic stem cells, cell lines H1, H7, andH9 .a 598 to 1283 1 to 684       684/684
(100 %)
3 diff
(99.6 %id)
BM741115 Ascites, stomach .a 634 to 1061 1 to 431       431/431
(100 %)
8 diff
(98.2 %id)
BM747147 Ascites, stomach .a 635 to 1169 1 to 535       535/535
(100 %)
1 diff
(99.9 %id)
AI767178 2 pooled tumors (clear cell type), Kidney .a 690 to 1261 572 to 1       572/574
(99 %)
12 diff
(98.0 %id)
CR741233 B-cell, chronic lymphotic leukemia .a 715 to 1042 1 to 328       328/328
(100 %)
1 diff
(99.7 %id)
BQ363759 stomach .a 717 to 1235 1 to 511       511/514
(99 %)
18 diff
(96.5 %id)
BX374185   .a 784 to 1636 866 to 1       866/877
(98 %)
54 diff
(93.9 %id)
BQ363760 stomach .a 788 to 1235 79 to 525       447/538
(83 %)
13 diff
(97.6 %id)
ES311450 frontal balding hair, skin .a 790 to 932 1 to 143       143/143
(100 %)
0 diff
(100 %id)
BP318500 pericardium .a 791 to 1373 1 to 583       583/583
(100 %)
1 diff
(99.9 %id)
BG110992 Bone, osteosarcoma, cell line .a 836 to 1622 1 to 784       784/966
(81 %)
18 diff
(98.2 %id)
BG777625 adenocarcinoma, Prostate .a 852 to 1630 1 to 775   AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 775/775
(100 %)
10 diff
(98.8 %id)
BM987067 mixed .a 860 to 1231 372 to 2   AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 371/372
(99 %)
1 diff
(99.8 %id)
BX356871 Placenta Cot 25-normalized .a 878 to 1603 726 to 1   fully sequenced,   726/726
(100 %)
1 diff
(99.9 %id)
BI836783 pooled pancreas and spleen .a 881 to 1621 1 to 748       748/827
(90 %)
17 diff
(98.0 %id)
TI_57164275   .a 882 to 1621 38 to 785   AAA   748/817
(91 %)
22 diff
(97.4 %id)
CB528537 Aveolar Macrophage, lung .a 884 to 1639 773 to 19   AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 755/755
(100 %)
2 diff
(99.8 %id)
BG209047   .a 909 to 1628 1 to 722       722/778
(92 %)
17 diff
(97.9 %id)
AI300528 2 pooled tumors (clear cell type), Kidney .a 937 to 1639 725 to 23   AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 703/703
(100 %)
0 diff
(100 %id)
BC116454.
matches multiple genes
epithelioid carcinoma, Pancreas, Pancreas, epithelioid carcinoma .a 957 to 1639 1 to 683   AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base), also hits gene ZNF878andZNF433 683/683
(100 %)
0 diff
(100 %id)
BQ233644 epithelioid carcinoma, Pancreas .a 959 to 1639 1 to 680   AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 680/680
(100 %)
1 diff
(99.9 %id)
BX387829 Placenta Cot 25-normalized .a 991 to 1599 616 to 1   fully sequenced,   616/616
(100 %)
55 diff
(91.1 %id)
BU784581 Pancreas, Purified pancreatic islet .a 1003 to 1639 637 to 1       637/637
(100 %)
0 diff
(100 %id)
AW075965 myeloid cells, 18 pooled CML cases, BCR/ABLrearrangement positive, includes both chronic phase andmyeloid blast crisis, whole blood .a 1045 to 1639 595 to 1       595/595
(100 %)
9 diff
(98.5 %id)
AW026303 brain, glioblastoma (pooled) .a 1055 to 1639 585 to 1       585/586
(99 %)
5 diff
(99.2 %id)
BM127157 Islets of Langerhans, Pancreas .a 1063 to 1639 595 to 19   AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 577/577
(100 %)
1 diff
(99.9 %id)
CK906069 Islets of Langerhans, Pancreas .a 1063 to 1639 595 to 19   AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 577/577
(100 %)
4 diff
(99.4 %id)
BU617720 Bone, Subchondral Bone .a 1072 to 1639 586 to 19   AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 568/568
(100 %)
3 diff
(99.5 %id)
AA829532 colon, colon tumor .a 1084 to 1641 562 to 5       558/562
(99 %)
0 diff
(100 %id)
AW970280   .a 1091 to 1638 547 to 1     Submitted on the opposite strand 547/570
(95 %)
18 diff
(96.9 %id)
TI_154038116   .a 1093 to 1639 604 to 57   AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 548/800
(68 %)
23 diff
(97.2 %id)
BM126596 Islets of Langerhans, Pancreas .a 1096 to 1639 562 to 19   AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 544/544
(100 %)
0 diff
(100 %id)
BU536780 mixed (pool of 40 RNAs) .a 1099 to 1641 8 to 550       543/583
(93 %)
3 diff
(99.5 %id)
BX328111   .a 1101 to 1641 1 to 541       541/541
(100 %)
6 diff
(98.9 %id)
BX342076   .a 1103 to 1576 499 to 25       475/589
(80 %)
0 diff
(100 %id)
BG025524 lymph, lymphoma, cell line .a 1140 to 1626 53 to 536       484/786
(61 %)
6 diff
(99.3 %id)
AA532842 colon .a 1174 to 1637 464 to 1       464/564
(82 %)
11 diff
(98.1 %id)
BF095633 uterus_tumor .a 1215 to 1588 383 to 10       374/383
(97 %)
0 diff
(100 %id)
AI392709 B-cell, chronic lymphotic leukemia .a 1228 to 1434 207 to 1       207/207
(100 %)
2 diff
(99.1 %id)
AI141143 lung .a 1233 to 1638 406 to 1       406/406
(100 %)
0 diff
(100 %id)
CA444596 lung, Metastatic Chondrosarcoma .a 1233 to 1639 425 to 19   AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 407/407
(100 %)
2 diff
(99.6 %id)
AI359065 brain, glioblastoma (pooled) .a 1239 to 1639 402 to 1       402/442
(90 %)
5 diff
(98.9 %id)
AI291797 placenta .a 1240 to 1641 404 to 3       402/404
(99 %)
0 diff
(100 %id)
BU851837 mixed (pool of 40 RNAs) .a 1242 to 1639 1 to 399       399/863
(46 %)
4 diff
(99.6 %id)
BF815726 colon_ins .a 1245 to 1579 338 to 4     Submitted on the opposite strand 335/338
(99 %)
0 diff
(100 %id)
AA761131 germinal center B cell .a 1250 to 1641 399 to 8       392/399
(98 %)
0 diff
(100 %id)
AA829256 germinal center B cell .a 1260 to 1625 366 to 1       366/366
(100 %)
1 diff
(99.8 %id)
AA825250 carcinoid, lung .a 1260 to 1639 397 to 18   AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 380/380
(100 %)
0 diff
(100 %id)
AW103157 pooled .a 1263 to 1639 377 to 1       377/377
(100 %)
0 diff
(100 %id)
AA027943 uterus .a 1270 to 1639 370 to 1       370/370
(100 %)
0 diff
(100 %id)
AA633742   .a 1292 to 1641 350 to 1       350/350
(100 %)
11 diff
(96.9 %id)
AA974950 Kidney .a 1300 to 1641 346 to 5       342/346
(98 %)
0 diff
(100 %id)
AI765708 2 pooled tumors (clear cell type), Kidney .a 1322 to 1638 328 to 12       317/328
(96 %)
0 diff
(100 %id)
BE242370 leukopheresis .a 1322 to 1639 318 to 1       318/318
(100 %)
3 diff
(99.1 %id)
AI873329 pooled .a 1333 to 1638 305 to 1       305/307
(99 %)
3 diff
(99.1 %id)
AI277475 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .a 1368 to 1641 275 to 2       274/275
(99 %)
0 diff
(100 %id)
AA744602 germinal center B cell .a 1369 to 1641 280 to 8       273/280
(97 %)
0 diff
(100 %id)
AI424113 brain, glioblastoma (pooled) .a 1371 to 1639 267 to 1       267/267
(100 %)
2 diff
(99.3 %id)
N62617 multiple sclerosis lesions .a 1424 to 1640 217 to 1       217/217
(100 %)
0 diff
(100 %id)
AA477375 ovarian tumor, ovary .a 1504 to 1641 1 to 138       138/182
(75 %)
1 diff
(99.5 %id)
CR597797 Placenta Cot 25-normalized .b 1 to 1489 1 to 1489   tiling clone,   1489/1489
(100 %)
0 diff
(100 %id)
AL544621 placenta, Placenta Cot 25-normalized .b 1 to 737 1 to 746   fully sequenced,   746/746
(100 %)
17 diff
(97.8 %id)
CR604430 T cells (Jurkat cell line) Cot10-normalized .b 36 to 1502 1 to 1467       1467/1467
(100 %)
0 diff
(100 %id)
AL558750 T cells from T cell leukemia .b 36 to 928 1 to 891   fully sequenced,   891/891
(100 %)
5 diff
(99.5 %id)
BX116472 multiple sclerosis lesions .b 337 to 1049 1 to 711       711/721
(98 %)
4 diff
(99.5 %id)
CR456860   .b 618 to 1009 1 to 392       392/396
(98 %)
2 diff
(99.5 %id)
AL570678 placenta, Placenta Cot 25-normalized .b 707 to 1489 782 to 1   fully sequenced,   782/782
(100 %)
5 diff
(99.4 %id)
AI564767 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus .b 793 to 1535 728 to 2       727/730
(99 %)
35 diff
(95.3 %id)
AL580500 T cells from T cell leukemia .b 898 to 1502 606 to 1   fully sequenced,   606/606
(100 %)
19 diff
(96.9 %id)
AI540142 B-cell, chronic lymphotic leukemia .b 1058 to 1535 479 to 2   tiling clone,   478/479
(99 %)
0 diff
(100 %id)
BI044841 ovary .c 1 to 407 426 to 21   tiling clone,   406/426
(95 %)
0 diff
(100 %id)
N44203 multiple sclerosis lesions .c 221 to 570 1 to 349       349/349
(100 %)
11 diff
(96.9 %id)
AF091086   .c 222 to 1520 10 to 1307 G62V V63F L64F L65C C66V ... tiling clone, AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 1298/1298
(100 %)
2 diff
(99.9 %id)
BP395273 pancreatic islet .c 756 to 1219 465 to 1       465/467
(99 %)
2 diff
(99.6 %id)
N34312 multiple sclerosis lesions .c 1067 to 1521 457 to 1   tiling clone,   457/457
(100 %)
15 diff
(96.8 %id)
AK300972 small intestine .d 1 to 1303 2 to 1304 V16L T168A tiling clone,   1304/1304
(100 %)
2 diff
(99.9 %id)
BM763666 myeloma .d 1 to 324 2 to 325       325/325
(100 %)
5 diff
(98.5 %id)
BE242888 leukopheresis .d 1 to 303 2 to 303   tiling clone,   303/303
(100 %)
3 diff
(99.1 %id)
CX761114 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .d 11 to 725 1 to 704 S202H Y203T W204G P205L Q206N ...   Submitted on the opposite strand 704/746
(94 %)
13 diff
(98.3 %id)
BQ066883 brain .d 18 to 551 70 to 605       536/1238
(43 %)
22 diff
(98.3 %id)
BM547364 ovary (pool of 3) .d 19 to 659 15 to 658       644/1205
(53 %)
14 diff
(98.9 %id)
CB150271 cervix, Uterine .d 40 to 536 1 to 497       497/497
(100 %)
1 diff
(99.8 %id)
CA843137 Pancreas, Purified pancreatic islet .d 41 to 635 35 to 629   tiling clone,   595/630
(94 %)
1 diff
(99.9 %id)
BQ378299 uterus_tumor .d 216 to 479 1 to 271       271/271
(100 %)
17 diff
(93.8 %id)
CD674223 eye, lens .d 226 to 526 1 to 301       301/301
(100 %)
0 diff
(100 %id)
BF801390 colon_ins .d 323 to 616 1 to 294       294/294
(100 %)
23 diff
(92.2 %id)
FN049480 breast carcinoma .d 572 to 633 64 to 4     Submitted on the opposite strand 61/65
(93 %)
0 diff
(100 %id)
CA843895 Pancreas, Purified pancreatic islet .d 1260 to 1795 537 to 1   tiling clone,   537/537
(100 %)
3 diff
(99.5 %id)
BI906263 leukocyte .e 1 to 908 9 to 928 V16L W20C L21C P22R G23A ... tiling clone,   928/929
(99 %)
28 diff
(97.0 %id)
TI_57232144   .e 1 to 908 69 to 988 V16L W20C L21C P22R G23A ...     928/989
(93 %)
21 diff
(97.9 %id)
CD356863 Blood vessels - aorta, basilar and artery .e 327 to 1059 1 to 738   tiling clone,   738/746
(98 %)
18 diff
(97.6 %id)
N94036 liver and spleen .f 1 to 412 13 to 430 A40Q G41A C42V T43L I44L ... tiling clone,   419/430
(97 %)
13 diff
(97.0 %id)
N69546 liver and spleen .f 985 to 1396 414 to 1   tiling clone,   414/414
(100 %)
2 diff
(99.6 %id)
AK023076   .g-u 1 to 2798 2 to 2798 V16L tiling clone, available from FLJ,   2798/2798
(100 %)
5 diff
(99.9 %id)
AU130306   .g-u 1 to 808 2 to 811 V16L capped   810/810
(100 %)
18 diff
(97.8 %id)
DA805074 brain .g-u 107 to 607 2 to 502   capped   501/501
(100 %)
1 diff
(99.9 %id)
DB450177 testis .g-u 258 to 706 1 to 451       451/453
(99 %)
11 diff
(97.6 %id)
DR422248 eye, Pterygium .g-u 446 to 1125 1 to 680       680/680
(100 %)
4 diff
(99.5 %id)
H08022 whole brain .g-u 843 to 1284 1 to 454       454/513
(88 %)
18 diff
(96.5 %id)
DA706780   .g-u 996 to 1458 2 to 464   capped   463/463
(100 %)
0 diff
(100 %id)
CB152084 brain .g-u 1005 to 1660 1 to 656       656/656
(100 %)
0 diff
(100 %id)
BM721380 eye, fetal eye .g-u 1032 to 1734 1 to 702       702/702
(100 %)
5 diff
(99.3 %id)
BF038390 adenocarcinoma, ovary .g-u 1102 to 1854 1 to 752       752/754
(99 %)
9 diff
(98.9 %id)
BX092802   .g-u 1552 to 2069 1 to 518   tiling clone,   518/518
(100 %)
0 diff
(100 %id)
R35613 whole brain .g-u 1604 to 1973 1 to 379       379/468
(80 %)
10 diff
(97.9 %id)
TI_151723733   .g-u 2224 to 3042 891 to 82   tiling clone, AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 810/910
(89 %)
13 diff
(98.6 %id)
AU152280   .g-u 2256 to 2796 543 to 3       541/553
(97 %)
0 diff
(100 %id)
DB515792 testis .g-u 2277 to 2721 1 to 446   AAA Submitted on the opposite strand 446/446
(100 %)
11 diff
(97.6 %id)
AI190916   .g-u 2292 to 2721 445 to 16   AAA   430/430
(100 %)
1 diff
(99.8 %id)
BF212372 bone marrow, from chronic myelogenous leukemia .g-u 2295 to 2832 1 to 541       541/950
(56 %)
32 diff
(96.7 %id)
AW074420 colon, juvenile granulosa tumor .g-u 2360 to 2716 357 to 1       357/357
(100 %)
0 diff
(100 %id)
AA199673   .g-u 2456 to 2720 269 to 3       267/304
(87 %)
0 diff
(100 %id)
H07923 whole brain .g-u 2748 to 3044 307 to 7   tiling clone,   301/344
(87 %)
0 diff
(100 %id)
DB146773 thymus .h-u 1 to 563 2 to 564 exact tiling clone, capped   563/563
(100 %)
0 diff
(100 %id)
EL948345 eyeball .i-u 1 to 480 1 to 478 exact tiling clone,   478/478
(100 %)
14 diff
(97.1 %id)
AK129583 rectum Gene COQ2, variant not shown       available from FLJ, Suspected internal deletion, suspected internal deletion, this clone was ignored    
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e, .f, .g-u, .h-u, .i-u Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes DC